Vasoconstriction: Causes, Symptoms & Effects on Blood Pressure

Vasoconstriction: Physiology, Triggers & Clinical Impact

Vasoconstriction—narrowing of blood vessel lumens via vascular smooth muscle contraction—is a fundamental hemodynamic mechanism with both protective and pathological roles.

Physiologic Triggers

  • Sympathetic activation: Norepinephrine → α₁-adrenergic receptors (skin, splanchnic, renal beds). "Fight-or-flight" redistribution.
  • Circulating catecholamines: Adrenal medulla epinephrine → α₁ (constriction) + β₂ (dilation in muscle) — net effect dose-dependent.
  • Angiotensin II: Potent vasoconstrictor (AT₁ receptors); RAAS activation.
  • Endothelin-1: Most potent endogenous vasoconstrictor; endothelial origin.
  • Vasopressin (ADH): V₁ receptors on vascular smooth muscle.
  • Local factors: Cold, hypoxia (pulmonary), thromboxane A₂, serotonin (damaged endothelium).

Physiologic Functions

  • Blood pressure homeostasis: Increases systemic vascular resistance (SVR).
  • Thermoregulation: Cutaneous vasoconstriction conserves heat.
  • Hemostasis: Reduces flow at injury sites.
  • Organ perfusion prioritization: Shunts blood from skin/gut/kidney to brain/heart during shock.
  • Vascular tone baseline: Maintains vascular "stiffness" for Windkessel effect.

Pathologic Vasoconstriction

Therapeutic Vasodilation

  • Calcium channel blockers (dihydropyridines: amlodipine)
  • Alpha-blockers (prazosin, doxazosin)
  • ACE inhibitors/ARBs (reduce Ang II)
  • Nitrates (NO donors)
  • Endothelin receptor antagonists (pulmonary hypertension)
  • Phosphodiesterase-5 inhibitors (pulmonary hypertension, Raynaud's)

Key Takeaway

Vasoconstriction is a vital homeostatic tool that becomes pathological when excessive, dysregulated, or misdirected. Understanding its triggers and vascular bed specificity guides targeted therapy.

Respiratory Disorders - Related Articles

Health Sciences © https://www.222health.com

ConditionMechanismConsequences
Essential hypertensionIncreased basal SVR, endothelial dysfunction, RAAS/SNS overactivityEnd-organ damage (heart, brain, kidney, vessels)
Raynaud phenomenonExaggerated cold/emotional digital vasospasmIschemic attacks (pallor→cyanosis→rubor); ulcer risk
Coronary vasospasmFocal epicardial artery constriction (Prinzmetal angina)Ischemia, infarction, arrhythmia, sudden death
Cerebral vasospasmPost-subarachnoid hemorrhage (days 3-14)Delayed cerebral ischemia, infarction
PreeclampsiaEndothelial dysfunction, vasoconstrictor sensitivityMaternal/fetal morbidity
Ergot/CA overdose, cocaine, amphetaminesDirect smooth muscle stimulation, SNS surgeAcute hypertension, ischemia, stroke